HB 616 Pennsylvania House · 2019-2020 Regular Session

An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for schedules of controlled substances.

Bill status signed all 5 stages cleared

Introduction

Feb 2019

Committee Review

Nov 2020

House Passage

Nov 2020

Senate Passage

Oct 2020

Signed into Law

Nov 2020

Introduced Feb 28, 2019 Signed Nov 25, 2020

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Nov 25, 2020

Signed into law

Approved by the Governor

lower

Nov 18, 2020

Lower · Passed

House concurred in Senate amendments

lower

Nov 18, 2020

Lower · Passed

Re-reported on concurrence, as committed

lower

Oct 26, 2020

Committee

Referred to RULES

lower

Oct 21, 2020

Upper · Passed

Third consideration and final passage

upper

Oct 21, 2020

Upper · Passed

Re-reported as committed

upper

Oct 19, 2020

Committee

Re-referred to APPROPRIATIONS

upper

Oct 6, 2020

Upper · Passed

PN 4473 Reported as amended

upper

Dec 26, 2019

Committee

Referred to JUDICIARY

upper

Dec 16, 2019

Lower · Passed

Third consideration and final passage

lower

Dec 16, 2019

Lower · Passed

Re-reported as committed

lower

Nov 21, 2019

Committee

Re-committed to APPROPRIATIONS

lower

Oct 22, 2019

Lower · Passed

PN 2760 Reported as amended

lower

Feb 28, 2019

Committee

PN 0611 Referred to JUDICIARY

lower

1 primary · 18 co-sponsors